These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7174308)

  • 1. A suggested register for pre-school screening and immunisation.
    Morris JB; Davidson M
    Health Bull (Edinb); 1982 Sep; 40(5):240-7. PubMed ID: 7174308
    [No Abstract]   [Full Text] [Related]  

  • 2. Opportunistic immunisation of infants admitted to hospital: are we doing enough?
    Ressler KA; Orr K; Bowdler S; Grove S; Best P; Ferson MJ
    J Paediatr Child Health; 2008 Jun; 44(6):317-20. PubMed ID: 18476924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective rubella vaccination programmes: a survey of districts in England and Wales.
    Gay NJ; Valambia S; Galasko D; Miller E
    Commun Dis Rep CDR Rev; 1994 Jun; 4(7):R77-9. PubMed ID: 7520802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register.
    Hull BP; McIntyre PB
    Commun Dis Intell; 2000 Jun; 24(6):161-4. PubMed ID: 10943030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation rates in Glasgow.
    McIntosh H; Martin I; Womersley J
    Health Bull (Edinb); 1981 Mar; 39(2):92-7. PubMed ID: 7239913
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inoculation rates of children starting school in Bavaria].
    Morlock G; Arenz S; Wildner M
    MMW Fortschr Med; 2005 Feb; 147(8):41, 43-4. PubMed ID: 18441564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient location on the standard immunisation recall system.
    Reay LM
    Health Bull (Edinb); 1986 Nov; 44(6):367-9. PubMed ID: 3818276
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the linkage of child care and maternity payments to childhood immunisation.
    Lawrence GL; MacIntyre CR; Hull BP; McIntyre PB
    Vaccine; 2004 Jun; 22(17-18):2345-50. PubMed ID: 15149795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination rates in childhood and adolescents are improved].
    Klein R; Manavi R
    Gesundheitswesen; 1997 Oct; 59(10):584-9. PubMed ID: 9453794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. School health service: review of 11 year old's screening programme.
    Morris JB; Hird MD
    Health Bull (Edinb); 1980 Jul; 38(4):153-9. PubMed ID: 7410050
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of seroconversion and duration of immunity induced by the meningococcal serogroup C vaccine. Study included in the evaluation of the mass immunization of the population in the age group between 18 months and 19 years in the community of Madrid].
    Ramírez Fernández R
    Rev Esp Salud Publica; 1998; 72(5):401-6. PubMed ID: 9951331
    [No Abstract]   [Full Text] [Related]  

  • 16. The epidemiology of Haemophilus influenzae invasive disease in Scotland prior to immunisation.
    Brewster D
    Health Bull (Edinb); 1993 Nov; 51(6):385-93. PubMed ID: 8307751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine uptake: new tools for investigating changes in age distribution and predicting final values.
    Cameron JC; Friederichs V; Robertson C
    Vaccine; 2007 Aug; 25(32):6078-85. PubMed ID: 17629364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increasing the immunization rate against measles, mumps, and rubella in medical students at the University of Berne].
    Germann D; Matter L
    Schweiz Med Wochenschr; 1999 Apr; 129(13):499-507. PubMed ID: 10322563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella epidemic: Scotland 1978. Comments on the rubella immunisation programmes.
    Edmond E; Morton P; Moffat M; Urquhart GE
    Health Bull (Edinb); 1980 Mar; 38(2):54-6. PubMed ID: 7380651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.